The International Regulatory Affairs Network
28.09.2009
Capacity of Healthcare Biotechnology in the New EU Member States
Biotech in the New EU Member States: Policy Recommendations The study carried-out on the development status and capacity of healthcare biotechnology in the new EU Member States and candidate countries shows a much contrasted picture of biotechnology development in this region. Each country has a different economic development strategy and a unique history and capacity in the life-science and healthcare sector which determines its path to development. Based on these observations, it would be unsuitable to propose general recommendations in a sort of unique formula to build or develop a healthy healthcare biotechnology sector. Donwnload free 14 pages report at our Download Section.
Farmavita.Net
